<DOC>
	<DOCNO>NCT00004937</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness acridine carboxamide treat patient recurrent glioblastoma multiforme .</brief_summary>
	<brief_title>Acridine Carboxamide Treating Patients With Recurrent Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy acridine carboxzmide term objective response rate response duration patient glioblastoma multiforme . II . Determine toxicities treatment regimen patient population . OUTLINE : This multicenter study . Patients receive acridine carboxamide IV continuously day 1-5 . Treatment repeat every 3 week least 2 course maximum 6 course absence disease progression unacceptable toxicity . Patients follow every 6 week disease progression . PROJECTED ACCRUAL : A total 14-25 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm recurrent glioblastoma multiforme Measurable disease contrast MRI Lesion least 2 cm diameter PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Karnofsky 70100 % Life expectancy : At least 3 month Hematopoietic : WBC great 3,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 2 time ULN Transaminases great 2 time ULN Renal : Creatinine great 1.5 mg/dL Cardiovascular : Normal cardiac function No ischemic heart disease within past 6 month Normal electrocardiogram Other : No unstable systemic diseases No active uncontrolled infection No prior concurrent malignancy except adequately treat basal squamous cell skin cancer carcinoma situ cervix No psychological , familial , sociological , geographical condition would preclude study Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 6 week since prior adjuvant chemotherapy brain tumor No prior chemotherapy Endocrine therapy : Must stable decreasing dos corticosteroids least 2 week Radiotherapy : At least 3 month since prior radiotherapy brain No prior high dose radiotherapy No prior stereotactic boost implant radiotherapy Surgery : No prior surgery ( except biopsy ) recurrent brain tumor At least 3 month since prior surgery primary brain tumor Other : No concurrent anticancer agents No concurrent investigational therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>